2020
DOI: 10.1016/j.jcmg.2019.03.029
|View full text |Cite
|
Sign up to set email alerts
|

The Prognostic Role of Late Gadolinium Enhancement in Aortic Stenosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
13
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
5
2
2

Relationship

0
9

Authors

Journals

citations
Cited by 33 publications
(15 citation statements)
references
References 35 publications
0
13
0
Order By: Relevance
“…Late gadolinium enhancement (LGE) by cardiac magnetic resonance (CMR) imaging detects myocardial fibrosis and a positive LGE-CMR has been shown to be present in 49% of patients with AS. Myocardial fibrosis identified by LV biopsy staining or LGE-CMR independently predicts mortality [20][21][22]. Recently, co-existing transthyretin wild type cardiac amyloidosis (ATTRwt) has been demonstrated in AS patients undergoing TAVR with a prevalence of 16% [23].…”
Section: Discussionmentioning
confidence: 99%
“…Late gadolinium enhancement (LGE) by cardiac magnetic resonance (CMR) imaging detects myocardial fibrosis and a positive LGE-CMR has been shown to be present in 49% of patients with AS. Myocardial fibrosis identified by LV biopsy staining or LGE-CMR independently predicts mortality [20][21][22]. Recently, co-existing transthyretin wild type cardiac amyloidosis (ATTRwt) has been demonstrated in AS patients undergoing TAVR with a prevalence of 16% [23].…”
Section: Discussionmentioning
confidence: 99%
“…Late gadolinium enhancement (LGE) by cardiac magnetic resonance (CMR) imaging detects myocardial brosis and a positive LGE-CMR has been shown to be present in 49% of patients with AS. Myocardial brosis identi ed by LV biopsy staining or LGE-CMR independently predicts mortality [20][21][22]. Recently, co-existing transthyretin wild type cardiac amyloidosis (ATTRwt) has been demonstrated in AS patients undergoing TAVR with a prevalence of 16% [23].…”
Section: Discussionmentioning
confidence: 99%
“…6,7,20,21 Recently, several studies have proposed different imaging parameters to assess LV function and identify LV decompensation. [22][23][24] LV GLS was associated with long-term outcomes independently of AS severity and LVEF. 22 Localized and diffuse LV fibrosis assessed using cardiac magnetic resonance late-gadolinium enhancement, T1 mapping, and extracellular volume assessment has shown a strong relation with prognosis in patients with severe AS.…”
Section: Evaluation Of LV Myocardial Function and Remodeling In Patients With Severe Asmentioning
confidence: 92%
“…22 Localized and diffuse LV fibrosis assessed using cardiac magnetic resonance late-gadolinium enhancement, T1 mapping, and extracellular volume assessment has shown a strong relation with prognosis in patients with severe AS. [23][24][25] Nevertheless, echocardiography remains the main imaging modality to diagnose and grade AS and also to assess LV adaptation to increased afterload. 26 Recently, Russell et al 8,9 developed a method to noninvasively calculate LV myocardial work indices, demonstrating that these parameters correlated well with invasive measures of myocardial work and metabolism evaluated using positron emission tomography.…”
Section: Evaluation Of LV Myocardial Function and Remodeling In Patients With Severe Asmentioning
confidence: 99%